How do transaminase changes with tigecycline depend on the dose?
Across tigecycline studies, liver enzyme (transaminase) elevations are described as part of the general pattern of adverse laboratory changes, but the provided information does not include a dose-by-dose breakdown. Because the dose–response data for transaminase changes (e.g., how the frequency or magnitude changes from lower to higher tigecycline doses) is not present here, it isn’t possible to quantify “vary by dose” from the information provided.
If you can share the specific study (or the dose arms) you’re looking at—such as a label table, a trial report, or the exact transaminase endpoint definition (ALT/AST frequency, grade, or mean change)—I can summarize how transaminase changes differ between those dose groups.
What transaminase endpoints are typically reported (and how dose variation is usually shown)?
When dose-related transaminase patterns are reported for tigecycline, they’re usually presented as one or more of the following:
- Incidence of ALT/AST elevations above a threshold (for example, more than 3x or 5x the upper limit of normal)
- Mean or median change from baseline in ALT/AST
- Proportion of patients meeting “clinically significant” liver enzyme criteria
- Dose/time relationship (e.g., early vs later elevations)
To determine variation by dose, you’d need the table/figure that cross-tabulates dose with one of these endpoints. That cross-tabulation is not included in the information available to me in this chat.
What to check in the study or prescribing information to answer this precisely
To get the dose relationship, look for a section or table that includes both:
1) The tigecycline dose arms (including any loading-dose arm vs maintenance-dose arm), and
2) The liver enzyme outcome definition (ALT/AST measure, threshold, and time window)
Common places are clinical trial adverse-event tables or laboratory monitoring sections in regulatory documents.
Next step
Send the dose arms (or paste the relevant table text) and specify whether you mean ALT, AST, or either. Then I can describe how the transaminase changes vary by dose, including the direction and magnitude.